Insulin aspart, recombinant Subcutaneous and Sodium Acetate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sodium Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sodium bicarbonate
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate Infant Injection
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate Injection
- Insulin aspart, recombinant Subcutaneous-Sodium bicarbonate Oral, Intravenous, Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate Tablets
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate, Citric Acid, and Simethicone Effervescent Granule Pkt
- Sodium Acetate-Insulin degludec
- Sodium Acetate-Insulin Degludec (U-100) Prefilled Pens
- Sodium Acetate-Insulin Degludec (U-100) Vials
- Sodium Acetate-Insulin Degludec (U-200) Prefilled Pens
- Sodium Acetate-Insulin degludec and liraglutide
- Sodium Acetate-Insulin degludec and liraglutide Subcutaneous